Suivre
Erik D Wold
Erik D Wold
Kisbee Therapeutics
Aucune adresse e-mail validée
Titre
Citée par
Citée par
Année
Synthesis of bispecific antibodies using genetically encoded unnatural amino acids
CH Kim, JY Axup, A Dubrovska, SA Kazane, BA Hutchins, ED Wold, ...
Journal of the American Chemical Society 134 (24), 9918-9921, 2012
2052012
Antibody conjugates with unnatural amino acids
TJ Hallam, E Wold, A Wahl, VV Smider
Molecular pharmaceutics 12 (6), 1848-1862, 2015
1312015
Self-assembled antibody multimers through peptide nucleic acid conjugation
SA Kazane, JY Axup, CH Kim, M Ciobanu, ED Wold, S Barluenga, ...
Journal of the American Chemical Society 135 (1), 340-346, 2013
1052013
A genetically encoded aza-Michael acceptor for covalent cross-linking of protein–receptor complexes
JL Furman, M Kang, S Choi, Y Cao, ED Wold, SB Sun, VV Smider, ...
Journal of the American Chemical Society 136 (23), 8411-8417, 2014
942014
Nicotinamide phosphoribosyltransferase can affect metastatic activity and cell adhesive functions by regulating integrins in breast cancer
AF Santidrian, SE LeBoeuf, ED Wold, M Ritland, JS Forsyth, BH Felding
DNA repair 23, 79-87, 2014
412014
Antibody Therapeutics in Oncology
ED Wold, VV Smider, BH Felding
Immunotherapy: Open Access 2 (1), 108, 2016
272016
Antibody microarrays utilizing site-specific antibody–oligonucleotide conjugates
ED Wold, R McBride, JY Axup, SA Kazane, VV Smider
Bioconjugate chemistry 26 (5), 807-811, 2015
182015
Synthesis of substituted Z-styrenes by Hiyama-type coupling of oxasilacycloalkenes: application to the synthesis of a 1-benzoxocane
JR Vyvyan, CA Engles, SL Bray, ED Wold, CL Porter, MO Konev
Beilstein Journal of Organic Chemistry 13 (1), 2122-2127, 2017
82017
Ectromelia-encoded virulence factor C15 specifically inhibits antigen presentation to CD4+ T cells post peptide loading
KS Forsyth, NH Roy, E Peauroi, BC DeHaven, ED Wold, AR Hersperger, ...
PLoS Pathogens 16 (8), e1008685, 2020
62020
Fc-small molecule antibody mimetics
ED Wold, JY Axup, BH Felding, VV Smider
Bioconjugate chemistry 26 (12), 2311-2314, 2015
62015
Antibody conjugates with unnatural amino acids Mol
TJ Hallam, E Wold, A Wahl, VV Smider
Pharmaceutics 12, 1848-1862, 2015
52015
Investigating the MHC class-II processing and presentation “network” via high-throughput small molecule screening.
ED Wold, D Schultz, S Cherry, LC Eisenlohr
The Journal of Immunology 200 (1_Supplement), 99.21-99.21, 2018
2018
Hiyama couplings of oxasilacycloalkenes: Synthesis of trisubstituted Z-styrenes and application to natural product skeletons
J Vyvyan, C Engles, S Bray, E Wold, C Porter, M Konev
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 253, 2017
2017
Immunotherapy: Open Access
ED Wold, VV Smider, BH Felding
2016
Discovery and Development of Novel Antibody Constructs for Cancer Diagnosis And Therapy
ED Wold
Scripps Research Institute, La Jolla, California, 2015
2015
Development of therapeutic antibody conjugates via unnatural amino acid chemistry
SA Kazane, BM Hutchins, ED Wold, JY Axup, CH Kim, TD Javahishvili, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 244, 2012
2012
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–16